Your browser doesn't support javascript.
loading
First-in-Human Phase I Study of Envafolimab, a Novel Subcutaneous Single-Domain Anti-PD-L1 Antibody, in Patients with Advanced Solid Tumors.
Papadopoulos, Kyriakos P; Harb, Wael; Peer, Cody J; Hua, Qiong; Xu, Siying; Lu, Haolan; Lu, Ni; He, Yue; Xu, Ting; Dong, Ruiping; Gong, John; Liu, David.
Afiliación
  • Papadopoulos KP; Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio, Texas, USA.
  • Harb W; Horizon Oncology Research, LLC, Horizon BioAdvance, Lafayette, Indiana, USA.
  • Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Hua Q; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • Xu S; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • Lu H; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • Lu N; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • He Y; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • Xu T; Alphamab Co., Ltd., Suzhou, People's Republic of China.
  • Dong R; Shanghai HaiHe Biopharma Pharmaceutical Co., Ltd., Shanghai, People's Republic of China.
  • Gong J; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
  • Liu D; 3D Medicines Co., Ltd., Sichuan, People's Republic of China.
Oncologist ; 26(9): e1514-e1525, 2021 09.
Article en En | MEDLINE | ID: mdl-33973293

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Límite: Aged / Female / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Límite: Aged / Female / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos